Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of STI571 (imatinib) with cytarabine in patients with chronic myeloid leukemia, includ…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating the combination of triapine (3-AP) with high-dose cytarabine in adults with advanced hematologic malignancies has c…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated the combination of imatinib mesylate and decitabine for chronic myeloid leukemia, including accelerated- …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update on Homoharringtonine for chronic myeloid leukemia, including chronic-phase and pediatric cases, with study sta…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study of bevacizumab, idarubicin, and cytarabine in patients with blast phase chronic myeloid leukemia (including BCR-ABL1-positiv…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa [Phase 2]
Phase 2 trial of STI571 (imatinib) in patients with chronic myeloid leukemia that has not responded to interferon alfa has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial update of imatinib mesylate for chronic myeloid leukemia has completed. The study included pediatric and BCR-ABL1–p…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [Phase 1]
Phase 1 trial evaluating FR901228 in pediatric patients with refractory or recurrent solid tumors or leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and imatinib mesylate in patients with chronic myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]
This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia
This clinical trial update reports completion of a study evaluating intracellular and plasma levels of imatinib in patients with chronic mye…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating sorafenib in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chronic …
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Phase 1]
Phase 1 study assessing the safety of adding sargramostim (GM-CSF) to chemotherapy in patients with refractory myeloid cancers; the trial ha…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating dasatinib in patients with chronic myeloid leukemia or acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Treatment Modification Based on Early Assessment of CML Patients [Phase 2]
A Phase 2 clinical trial update discussing treatment modification for chronic myeloid leukemia patients based on early assessment.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
This update summarizes a Phase 1/2 clinical trial of a vaccine therapy with an immune adjuvant in patients with chronic myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies [NA]
A completed clinical trial evaluating hematopoietic cell transplantation from sibling and unrelated donors in patients with hematologic mali…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML [Phase 3]
Phase 3 clinical trial comparing bosutinib to imatinib in newly diagnosed chronic phase Philadelphia chromosome–positive chronic myeloid leu…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™ [Phase 2]
This report updates a Phase 2 trial of AG-858 in patients with chronic myeloid leukemia who remain cytogenetically positive after treatment …
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating safety and efficacy of imatinib in chronic myeloid leukemia patients who relapse after stem cell transplantation. T…